Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georgia Metzgeroth

Showing results (61-70 of 90) with videos related to

Pageof 9
Sort By:
Haematologica|October 15, 2020
Replication stress signaling is a therapeutic target in myelodysplastic syndromes with splicing factor mutationsJohanna Flach, Johann-Christoph Jann, Antje Knaflic, et al.
Genes, Chromosomes & Cancer|January 18, 2018
Incidence and prognostic impact of cytogenetic aberrations in patients with systemic mastocytosisNicole Naumann, Mohamad Jawhar, Juliana Schwaab, et al.
British Journal of Haematology|June 1, 2021
Clinical and histopathological features of myeloid neoplasms with concurrent Janus kinase 2 (JAK2) V617F and KIT proto-oncogene, receptor tyrosine kinase (KIT) D816V mutationsNicole Naumann, Johannes Lübke, William Shomali, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 19, 2020
Importance of Adequate Diagnostic Workup for Correct Diagnosis of Advanced Systemic MastocytosisJuliana Schwaab, Nicole Cabral do O Hartmann, Nicole Naumann, et al.
The Journal of Allergy and Clinical Immunology|March 31, 2012
Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromesPeter Valent, Amy D Klion, Hans-Peter Horny, et al.
Annals of Hematology|February 27, 2024
Treatment with the apoptosis inhibitor Asunercept reduces clone sizes in patients with lower risk Myelodysplastic NeoplasmsAlexander Streuer, Johann-Christoph Jann, Tobias Boch, et al.
Blood|August 21, 2013
Comprehensive mutational profiling in advanced systemic mastocytosisJuliana Schwaab, Susanne Schnittger, Karl Sotlar, et al.
British Journal of Haematology|October 13, 2025
Primary CD34<sup>+</sup> cells of patients with vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome are highly sensitive to targeted treatment with TAK-243Daniel Nowak, Marie Demmerle, Alessa Klär, et al.
International Journal of Molecular Sciences|April 3, 2021
Adverse Prognostic Impact of the <i>KIT</i> D816V Transcriptional Activity in Advanced Systemic MastocytosisNicole Naumann, Johannes Lübke, Sofie Baumann, et al.
Expert Review of Hematology|April 6, 2012
Pathogenesis and classification of eosinophil disorders: a review of recent developments in the fieldPeter Valent, Gerald J Gleich, Andreas Reiter, et al.
Pageof 9

Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
Haematologica|October 15, 2020
Replication stress signaling is a therapeutic target in myelodysplastic syndromes with splicing factor mutationsJohanna Flach, Johann-Christoph Jann, Antje Knaflic, et al.
Genes, Chromosomes & Cancer|January 18, 2018
Incidence and prognostic impact of cytogenetic aberrations in patients with systemic mastocytosisNicole Naumann, Mohamad Jawhar, Juliana Schwaab, et al.
British Journal of Haematology|June 1, 2021
Clinical and histopathological features of myeloid neoplasms with concurrent Janus kinase 2 (JAK2) V617F and KIT proto-oncogene, receptor tyrosine kinase (KIT) D816V mutationsNicole Naumann, Johannes Lübke, William Shomali, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 19, 2020
Importance of Adequate Diagnostic Workup for Correct Diagnosis of Advanced Systemic MastocytosisJuliana Schwaab, Nicole Cabral do O Hartmann, Nicole Naumann, et al.
The Journal of Allergy and Clinical Immunology|March 31, 2012
Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromesPeter Valent, Amy D Klion, Hans-Peter Horny, et al.
Annals of Hematology|February 27, 2024
Treatment with the apoptosis inhibitor Asunercept reduces clone sizes in patients with lower risk Myelodysplastic NeoplasmsAlexander Streuer, Johann-Christoph Jann, Tobias Boch, et al.
Blood|August 21, 2013
Comprehensive mutational profiling in advanced systemic mastocytosisJuliana Schwaab, Susanne Schnittger, Karl Sotlar, et al.
British Journal of Haematology|October 13, 2025
Primary CD34<sup>+</sup> cells of patients with vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome are highly sensitive to targeted treatment with TAK-243Daniel Nowak, Marie Demmerle, Alessa Klär, et al.
International Journal of Molecular Sciences|April 3, 2021
Adverse Prognostic Impact of the <i>KIT</i> D816V Transcriptional Activity in Advanced Systemic MastocytosisNicole Naumann, Johannes Lübke, Sofie Baumann, et al.
Expert Review of Hematology|April 6, 2012
Pathogenesis and classification of eosinophil disorders: a review of recent developments in the fieldPeter Valent, Gerald J Gleich, Andreas Reiter, et al.
Pageof 9